Introduction: The present study aimed at testing the longitudinal feasibility of the Montreal Cognitive Assessment (MoCA) in an Italian cohort of non-demented amyotrophic lateral sclerosis (ALS) patients. Methods:N = 39 non-demented ALS patients were followed-up at a 5-to-10-month interval (M = 6.8; SD = 1.4) with the MoCA and the Edinburgh Cognitive and Behavioral ALS Screen (ECAS). Practice effects, test-retest reliability, and predictive validity (against follow-up ECAS scores) were assessed. Reliable change indices (RCIs) were derived via a regression-based approach by accounting for retest interval and baseline confounders (i.e., demographics, disease duration, and severity and progression rate). Results: At retest, 100% and 69.2% of patients completed the ECAS and the MoCA, respectively. Patients who could not complete the MoCA showed a slightly more severe and fast-progressing disease. The MoCA was not subject to practice effects (t[32] = −0.80; p = 0.429) and was reliable at retest (intra-class correlation = 0.82). Moreover, baseline MoCA scores predicted the ECAS at retest. RCIs were successfully derived – with baseline MoCA scores being the only significant predictor of retest performances (ps < 0.001). Conclusions: As long as motor disabilities do not undermine its applicability, the MoCA appears to be longitudinally feasible at a 5-to-10-month interval in non-demented ALS patients. However, ALS-specific screeners – such as the ECAS – should be preferred whenever possible.

1.
Finsel
J
,
Uttner
I
,
Vázquez Medrano
CR
,
Ludolph
AC
,
Lulé
D
.
Cognition in the course of ALS: a meta-analysis
.
Amyotroph Lateral Scler Frontotemporal Degener
.
2023
;
24
(
1–2
):
2
13
.
2.
Gosselt
IK
,
Nijboer
TC
,
Van Es
MA
.
An overview of screening instruments for cognition and behavior in patients with ALS: selecting the appropriate tool for clinical practice
.
Amyotroph Lateral Scler Frontotemporal Degener
.
2020
;
21
(
5–6
):
324
36
.
3.
Aiello
EN
,
Solca
F
,
Torre
S
,
Carelli
L
,
Monti
A
,
Ferrucci
R
, et al
.
Reliable change indices for the Italian Edinburgh cognitive and behavioral ALS screen (ECAS)
.
Amyotroph Lateral Scler Frontotemporal Degener
.
2023
;
24
(
3–4
):
339
42
.
4.
Aiello
EN
,
Solca
F
,
Torre
S
,
Carelli
L
,
Ferrucci
R
,
Priori
A
, et al
.
Diagnostics and clinical usability of the Montreal Cognitive Assessment (MoCA) in amyotrophic lateral sclerosis
.
Front Psychol
.
2022
;
13
:
1012632
6
.
5.
Aiello
EN
,
Gramegna
C
,
Esposito
A
,
Gazzaniga
V
,
Zago
S
,
Difonzo
T
, et al
.
The Montreal Cognitive Assessment (MoCA): updated norms and psychometric insights into adaptive testing from healthy individuals in Northern Italy
.
Aging Clin Exp Res
.
2022
;
34
(
2
):
375
82
.
6.
Poletti
B
,
Solca
F
,
Carelli
L
,
Madotto
F
,
Lafronza
A
,
Faini
A
, et al
.
The validation of the Italian Edinburgh cognitive and behavioural ALS screen (ECAS)
.
Amyotroph Lateral Scler Frontotemporal Degener
.
2016
;
17
(
7–8
):
489
98
.
7.
Cedarbaum
JM
,
Stambler
N
,
Malta
E
,
Fuller
C
,
Hilt
D
,
Thurmond
B
, et al
.
The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III)
.
J Neurol Sci
.
1999
;
169
(
1–2
):
13
21
.
8.
Kimura
FC
,
Fujimura
C
,
Ishida
S
,
Nakajima
H
,
Furutama
D
,
Uehara
H
, et al
.
Progression rate of ALSFRS-R at time of diagnosis predicts survival time in ALS
.
Neurology
.
2006
;
66
(
2
):
265
7
.
9.
Duff
K
.
Evidence-based indicators of neuropsychological change in the individual patient: relevant concepts and methods
.
Arch Clin Neuropsychol
.
2012
;
27
(
3
):
248
61
.
10.
Poletti
B
,
Solca
F
,
Carelli
L
,
Faini
A
,
Madotto
F
,
Lafronza
A
, et al
.
Cognitive-behavioral longitudinal assessment in ALS: the Italian Edinburgh Cognitive and Behavioral ALS screen (ECAS)
.
Amyotroph Lateral Scler Frontotemporal Degener
.
2018
;
19
(
5–6
):
387
95
.
You do not currently have access to this content.